Page last updated: 2024-11-04

sk&f 97541 and Gelineau Syndrome

sk&f 97541 has been researched along with Gelineau Syndrome in 1 studies

3-aminopropyl(methyl)phosphinic acid: structure given in first source; GABA-A receptor antagonist

Research Excerpts

ExcerptRelevanceReference
" At 100 mg/kg, CGP35348 shifted the dose-response curves of baclofen and SKF97541 to the right but not those of GHB and GBL; at 320 mg/kg, CGP35348 shifted the curves of all four compounds to the right."1.34Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348. ( Coop, A; Koek, W; Mercer, SL, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koek, W1
Mercer, SL1
Coop, A1

Other Studies

1 other study available for sk&f 97541 and Gelineau Syndrome

ArticleYear
Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348.
    Psychopharmacology, 2007, Volume: 192, Issue:3

    Topics: 4-Butyrolactone; Animals; Baclofen; Catalepsy; Dose-Response Relationship, Drug; GABA Agonists; GABA

2007